INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.
Continuously Updated

NMPA Regulations

China medical device regulations and NMPA regulatory updates — tracked continuously and interpreted with submission practice in mind.

RegulationsNMPA AnnouncementsGuidancePractice Notes
KEY REGULATIONS

Key Regulations at a Glance

The core documents shaping China's medical device regulatory framework — the regulatory baseline every overseas manufacturer should know.

State Council Decree No. 739

Regulations on the Supervision and Administration of Medical Devices

Effective June 1, 2021

The cornerstone regulation: registrant (legal agent) system, risk-based classification and full lifecycle oversight.

Master Framework
SAMR Order No. 47

Measures for Registration and Filing of Medical Devices

Effective October 1, 2021

Core procedural rules for device registration and filing: dossiers, review, changes and renewals.

Registration
SAMR Order No. 48

Measures for Registration and Filing of In Vitro Diagnostic Reagents

Effective October 1, 2021

The dedicated registration and filing route for in vitro diagnostic reagents, alongside the device measures.

IVD
SAMR Order No. 53

Measures for Supervision of Medical Device Production

Effective May 1, 2022

Production licensing, commissioned manufacturing and cross-region oversight requirements.

Manufacturing
SAMR Order No. 54

Measures for Supervision of Medical Device Distribution

Effective May 1, 2022

Distribution licensing, incoming inspection and trading compliance requirements.

Distribution
Announcement No. 104 (2017)

Medical Device Classification Catalogue

Effective August 1, 2018 · dynamic

22 sub-catalogues defining device classes — the starting point for filing vs. registration pathways.

Classification
Regulatory information on this page is a general summary and does not constitute legal advice. The official NMPA publications and current regulations always prevail.
NMPA UPDATES

NMPA Updates

Amendments, announcements and new guidance — tracked here with practical implications for overseas manufacturers. Click any article to read the full text.

Practical GuideOctober 2026 Read

How to register a medical device in China

The complete pathway for foreign manufacturers: classification, agent, dossier, testing, clinical evaluation, statutory timelines and costs.

Practical GuideOctober 2026 Read

China legal agent: duties, requirements & change

Legal basis of the in-country representative, how it differs from distributors and EU authorized reps, and how to switch agents safely.

Practical GuideOctober 2026 Read

Clinical evaluation: exemptions, equivalence & trials

Choose the fastest defensible evidence route: exemption catalogue, same-variety evaluation, trials and foreign data.

Practical GuideOctober 2026 Read

How to enter the Chinese medical device market

Import rules, roles (agent vs distributor vs importer), special pathways and a ten-step entry roadmap.

Regulatory AnalysisOctober 2026 Read

Key points of Decree No. 739 for overseas manufacturers

Core obligations of overseas registrants, China legal agents and post-market duties under the revised Regulations.

Regulatory AnalysisOctober 2026 Read

Classification Catalogue dynamic adjustments explained

How the catalogue is updated, and what adjustments mean for products already on or entering the market.

NMPA AnnouncementsOctober 2026 Read

UDI rollout tracker

Implementation batches, product scope and a step-by-step checklist for overseas manufacturers.

NMPA AnnouncementsOctober 2026 Read

Announcements & guidance tracker

The latest NMPA announcements, classification determinations and guidance — with impact notes for exporters.

Practice Q&AOctober 2026 Read

Post-market obligations & vigilance Q&A

Ongoing duties, vigilance reporting timelines and recall coordination — in practical terms.

Practice Q&AOctober 2026 Read

Submission practice Q&A

Pathways, dossier preparation and common questions — based on our hands-on registration coordination.

Regulation Library Browse all articles and past updates — continuously maintained
MILESTONES

Regulatory Milestones

A few key moments that shaped China's medical device regulatory framework.

2018

NMPA Established

The National Medical Products Administration inaugurated, unifying drug and device regulation.

2021.06

Revised Regulations in Force

The revised Regulations (State Council Decree No. 739) take effect; the registrant system fully implemented.

2021.10

New Registration Rules

Measures for Registration & Filing (Orders No. 47 & 48) take effect on the same day.

2022.05

Production & Distribution Rules

Production (No. 53) and distribution (No. 54) measures complete the regulatory chain.

Today

Continuous Tracking

NMPA announcements, guidance and standards — tracked on this page, updated continuously.

Questions about a regulation?

Beyond updates, we'd be glad to discuss your product and your route into the Chinese market.